AbbVie Will Use Allergan Revenue To Fund Combined Firm's Large R&D Pipeline

 
• By Mandy Jackson
  
R&D
Botox and other Allergan products will fund AbbVie's diversification. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business